Gastroenterology
Volume 128, Issue 2 , Pages 343-350, February 2005

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C

  • Laurent Castéra

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
    • Corresponding Author InformationAddress requests for reprints to: Laurent Castera, MD, Service d’Hépato-Gastroentérologie, Hôpital Haut Lévêque, Avenue Magellan, 33604 Pessac, France; fax: (33) 5 57 65 64 45
  • ,
  • Julien Vergniol

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
  • ,
  • Juliette Foucher

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
  • ,
  • Brigitte Le Bail

      Affiliations

    • Service d’Anatomo-Pathologie, Hôpital Pellegrin, C.H.U. Bordeaux, Bordeaux
    • INSERM E362 IFR66 Université Victor Segalen, Bordeaux, France
  • ,
  • Elise Chanteloup

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
  • ,
  • Maud Haaser

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
  • ,
  • Monique Darriet

      Affiliations

    • Laboratoire de Biochimie, Hôpital Pellegrin, C.H.U. Bordeaux, Bordeaux
  • ,
  • Patrice Couzigou

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
  • ,
  • Victor de Lédinghen

      Affiliations

    • Service d’Hépato-gastroentérologie, Hôpital Haut Lévêque, C.H.U. Bordeaux, Pessac
    • INSERM E362 IFR66 Université Victor Segalen, Bordeaux, France

Received 28 July 2004; accepted 4 November 2004.

Background & Aims: Transient elastography (FibroScan; Echosens, Paris, France) is a novel, noninvasive, and rapid bedside method to assess liver fibrosis by measuring liver stiffness. We prospectively assessed the performance of FibroScan in patients with chronic hepatitis C, in comparison with and combined with currently available biochemical markers (Fibrotest; Biopredictive; and the aspartate transaminase to platelets ratio index [APRI]); a liver biopsy examination performed the same day served as the reference. Methods: We studied 183 consecutive patients with chronic hepatitis C (METAVIR fibrosis stage F1, n = 47; F2, n = 53; F3, n = 37; F4, n = 46). Results: FibroScan values ranged from 2.4 to 75.4 kilopascals (median, 7.4 kilopascals). Cut-off values were 7.1 kPa for F ≥ 2, 9.5 kPa for F ≥ 3, and 12.5 kPa for F = 4. The areas under the receiver operating characteristic (ROC) curve of FibroScan, FibroTest, and APRI values were of the same order (.83, .85, and .78, respectively, for F ≥ 2; .90, .90, and .84, respectively, for F ≥ 3; and .95, .87, and .83, respectively, for F = 4). The best performance was obtained by combining the FibroScan and FibroTest, with areas under the ROC curve of .88 for F ≥ 2, .95 for F ≥ 3, and .95 for F = 4. When the FibroScan and FibroTest results agreed, liver biopsy examination confirmed them in 84% of cases for F ≥ 2, in 95% for F ≥ 3, and in 94% for F = 4. Conclusions: FibroScan is a simple and effective method for assessing liver fibrosis, with similar performance to FibroTest and APRI. The combined use of FibroScan and FibroTest to evaluate liver fibrosis could avoid a biopsy procedure in most patients with chronic hepatitis C.

Abbreviations used in this paper:  AUROC, area under the receiver operating characteristic , CHC, chronic hepatitis C , CI, confidence interval , FS, FibroScan , FT, FibroTest , kPa, kilopascal , LB, liver biopsy , ROC, receiver operating characteristic

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The Fibroscan devices were made available for the study by Echosens (Paris, France).

PII: S0016-5085(04)02029-3

doi:10.1053/j.gastro.2004.11.018

Gastroenterology
Volume 128, Issue 2 , Pages 343-350, February 2005